Telling Body Time

A new method could make it easier to assess a person's circadian rhythms, paving the way for increased drug effectiveness.

Written byHayley Dunning
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Circadian rhythms dictate the 24-hour shifts in gene expression, protein levels, and various cellular processes throughout the day, such as melatonin affecting our sleep-wake cycle. Such changes in cell activity—in particular, cyclical changes in metabolism— can greatly influence the effectiveness of a drug and the severity of its side effects, depending on when it is administered.

However, each individual has unique circadian timing, with "body time" being offset by as much as 6 hours between people, making it difficult—if not impossible—for doctors to take into account when giving drugs. Previous attempts to assess a person's body time have relied on intense, repeated sampling procedures that were impractical for clinical applications. But in a study, published yesterday (August 27) in Proceedings of the National Academy of Sciences, researchers have demonstrated a new method that requires only two blood samples, taken 12 hours apart.

"Due to a combination of genetics and environment, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies